Coronavirus disease (COVID-19) is an infectious disease caused by the coronavirus SARS-CoV-2. Here we have collected APR news related to the COVID-19 pandemic, vaccination efforts and emerging treatments.
Two teams of infectious disease researchers in Italy say they have further analyzed the SARS-CoV-2 genome from samples acquired locally to generate early data that reveal a level of genetic ...
read more
In recent months, the world has been dealing with an outbreak of a novel coronavirus, designated COVID-19. Requirements have been established for facial masks, social distancing, gloves, and 20 second...
read more
Thursday, August 20, 2020
The FDA is alerting clinical laboratory staff and health care providers of a risk of false results with Thermo Fisher Scientific TaqPath COVID-19 Combo Kit.
read more
During the COVID-19 pandemic, the delivery of healthcare and the supply chains for critical reagents and supplies needed for the manufacturing both of established and novel therapies have been ...
read more
Tuesday, October 13, 2020
The trends affecting the biopharma industry that we’ve evaluated over the past decade have remained relatively stable. In this highly regulated healthcare industry segment, decision-makers often ...
read more
Three human coronaviruses originating from zoonotic events are responsible for severe acute respiratory syndrome outbreaks around the world. The first two, SARS-CoV and MERS-CoV were disseminated by ...
read more
Wednesday, March 31, 2021
Canada's National Advisory Committee on Immunization has recommended the AstraZeneca Covid-19 vaccine should not be used in adults under age 55 while rare cases of serious blood clots following ...
read more
AstraZeneca would like to clarify a number of inaccurate statements relating to COVID-19 Vaccine AstraZeneca doses at the Anagni plant in Italy.
read more
In participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those reported in trial of vaccinated 16-25 year old participants in an earlier ...
read more
Mologic today announced its rapid antigen self-test for COVID-19 has been selected by the Rapid Acceleration of Diagnostics (RADxSM) initiative launched by the U.S. National Institutes of Health.
read more
Preliminary Phase 1b findings in participants receiving the dual antigen hAd5 S + N vaccine generated Th1 dominant S and N specific T cells after a single prime subcutaneous injection.
read more
Moderna, Inc. highlighted today the publication of antibody persistence data out to 6 months following the second dose of the Moderna COVID-19 Vaccine in The New England Journal of Medicine.
read more
AstraZeneca announced high-level results from the DARE-19 Phase III trial assessing Farxiga to treat patients hospitalized with COVID-19.
read more
Wednesday, April 14, 2021
The following statement is attributed to Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research and Dr. Anne Schuchat, Principal Deputy Director of the CDC.
read more
Today, the U.S. Food and Drug Administration revoked the EUA that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of ...
read more